(S (NP (DT This) (NN paper)) (VP (VBZ presents) (NP (NP (DT an) (NN analysis)) (PP (IN of) (SBAR (WHADVP (WRB how)) (S (NP (DT the) (NN iris) (NN recognition)) (VP (VBZ is) (VP (VBN impacted) (PP (IN by) (NP (NP (NN eye) (NNS diseases)) (CC and) (NP (DT an) (JJ appropriate) (NN dataset)))) (S (VP (VBG comprising) (NP (NP (CD 2996) (NN iris) (NNS images)) (PP (IN of) (NP (NP (CD 230) (JJ distinct) (NNS eyes)) (-LRB- -LRB-) (PP (VBG including) (NP (NP (ADJP (NP (CD 184) (NN illness)) (HYPH -) (VBN affected)) (NNS eyes)) (VP (VBG representing) (NP (QP (JJR more) (IN than) (CD 20)) (JJ different) (NN eye) (NNS conditions))))) (-RRB- -RRB-))))))))))))) (. .))
(S (NP (DT The) (NNS images)) (VP (VBD were) (VP (VBN collected) (PP (IN in) (NP (JJ near) (NML (JJ infrared) (CC and) (JJ visible)) (NN light))) (PP (IN during) (NP (DT a) (JJ routine) (JJ ophthalmological) (NN practice))))) (. .))
(S (NP (DT The) (JJ experimental) (NN study)) (VP (VBZ shows) (NP (CD four) (JJ valuable) (NNS results))) (. .))
(S (ADVP (RB First)) (, ,) (NP (DT the) (NN enrollment) (NN process)) (VP (VBZ is) (ADJP (RB highly) (JJ sensitive) (PP (IN to) (NP (NP (DT those) (NN eye) (NNS conditions)) (SBAR (WHNP (WDT that)) (S (VP (VBP make) (SBAR (S (NP (DT the) (NN iris)) (VP (VP (VBD obstructed)) (CC or) (VP (VB introduce) (NP (JJ geometrical) (NNS distortions))))))))))))) (. .))
(S (ADVP (RB Second)) (, ,) (NP (NP (RB even) (DT those) (NNS conditions)) (SBAR (WHNP (WDT that)) (S (VP (VBP do) (RB not) (VP (VB produce) (NP (JJ visible) (NNS changes)) (PP (IN to) (NP (DT the) (NN iris) (NN structure)))))))) (VP (MD may) (VP (VB increase) (NP (DT the) (NN dissimilarity)) (PP (IN among) (NP (NP (NNS samples)) (PP (IN of) (NP (DT the) (JJ same) (NNS eyes))))))) (. .))
(S (ADVP (JJ Third)) (, ,) (NP (NP (NN eye) (NNS conditions)) (VP (VBG affecting) (NP (NP (NN iris) (NN geometry)) (, ,) (NP (PRP$ its) (NN tissue) (NN structure)) (CC or) (NP (VBG producing) (NNS obstructions))))) (ADVP (RB significantly)) (VP (VBP decrease) (NP (DT the) (NN iris) (NN recognition) (NN reliability))) (. .))
(S (ADVP (RB Fourth)) (, ,) (PP (IN for) (NP (NP (NNS eyes)) (VP (VBN afflicted) (PP (IN by) (NP (DT a) (NN disease)))))) (, ,) (NP (NP (DT the) (ADJP (RBS most) (JJ prominent)) (NN effect)) (PP (IN of) (NP (NP (DT the) (NN disease)) (PP (IN on) (NP (NN iris) (NN recognition)))))) (VP (VBZ is) (S (VP (TO to) (VP (VB cause) (NP (NN segmentation) (NNS errors)))))) (. .))
(S (PP (IN To) (NP (PRP$ our) (NN knowledge))) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (NN database)) (PP (IN of) (NP (NP (NP (NN iris) (NNS images)) (SBAR (IN for) (S (NP (ADJP (NN disease) (HYPH -) (VBN affected)) (NNS eyes)) (VP (VBD made) (ADJP (RB publicly) (JJ available)) (PP (IN to) (NP (NNS researchers))))))) (, ,) (CC and) (NP (NP (DT the) (ADJP (RBS most) (JJ comprehensive)) (NN study)) (PP (IN of) (SBAR (WHNP (WP what)) (S (NP (PRP we)) (VP (MD can) (VP (VB expect) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN iris) (NN recognition)) (VP (VBZ is) (VP (VBN deployed) (PP (IN for) (NP (JJ non-healthy) (NNS eyes))))))))))))))))) (. .))
